Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

2017 NCCN Annual Conference

Christina S. Chu, MD, of Fox Chase Cancer Center, discusses the link between human papillomavirus and genital cancers and what is known about the effect of HPV on treatment response and outcome.

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Suzanne George, MD, of Dana-Farber Cancer I...

Pancreatic Cancer

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Margaret A. Tempero, MD, of the UCSF Helen ...

Hematologic Malignancies

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Ruben A. Mesa, MD, of the Mayo Clinic Cance...

Bladder Cancer

Elizabeth R. Plimack, MD, on Bladder Cancer: Management Updates

Elizabeth R. Plimack, MD, of Fox Chase Canc...

Issues in Oncology

Paul M. Cinciripini, PhD, on Smoking Cessation in Patients With Cancer

Paul M. Cinciripini, PhD, of The University...

Sep

Today In Oncology

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

Related Videos

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Elizabeth R. Plimack, MD, on Bladder Cancer: Management Updates

Paul M. Cinciripini, PhD, on Smoking Cessation in Patients With Cancer

Caring for Undocumented Patients With Cancer

First-Line PD-1 Inhibitor With or Without Chemotherapy vs Chemotherapy Alone in Advanced Gastric Cancer

Osimertinib vs Platinum/Pemetrexed in Patients With EGFR T790M Advanced NSCLC

Addition of Veliparib to Carboplatin/Paclitaxel in Previously Treated Patients With BRCA-Mutated Advanced Breast Cancer

Does Binimetinib Improve Progression-Free Survival in Recurrent or Persistent Low-Grade Serous Ovarian Carcinomas